Matinas BioPharma Holdings, Inc. Annual Costs and Expenses in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Matinas BioPharma Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from 2015 to 2023.
  • Matinas BioPharma Holdings, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $5.84M, a 5.2% decline year-over-year.
  • Matinas BioPharma Holdings, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $23.8M, a 8.29% decline year-over-year.
  • Matinas BioPharma Holdings, Inc. annual Costs and Expenses for 2023 was $24.9M, a 10.5% decline from 2022.
  • Matinas BioPharma Holdings, Inc. annual Costs and Expenses for 2022 was $27.8M, a 12.2% increase from 2021.
  • Matinas BioPharma Holdings, Inc. annual Costs and Expenses for 2021 was $24.8M, a 1.65% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $24.9M -$2.92M -10.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $27.8M +$3.01M +12.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $24.8M +$403K +1.65% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $24.4M +$5.35M +28.2% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-03-11
2019 $19M +$4.24M +28.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $14.8M -$1.89M -11.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $16.7M +$8.39M +102% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $8.26M -$1.85M -18.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $10.1M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.